Text Size
56 studies found for:    Open Studies | "Urticaria"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
Conditions: Chronic Urticaria;   Chronic Idiopathic Urticaria;   Chronic Spontaneous Urticaria
Interventions: Drug: Omalizumab (Xolair);   Drug: Placebo
2 Recruiting Profiling Urticaria for the Identification of Subtypes
Conditions: Non-autoreactive Chronic Spontaneous Urticaria;   Autoimmune Chronic Spontaneous Urticaria;   Autoreactive, Non-autoimmune Chronic Spontaneous Urticaria
Intervention:
3 Unknown † The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
Conditions: Chronic Idiopathic Urticaria;   Urticaria
Intervention: Drug: Denosin® and Xyzal®
4 Not yet recruiting The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
Conditions: Urticaria;   Angioedema;   Hives;   Swelling
Intervention: Drug: Vitamin D
5 Recruiting Validation of an Urticaria Control Test
Condition: Chronic Urticaria
Intervention:
6 Recruiting Development of an Urticaria Control Test
Condition: Chronic Urticaria
Intervention:
7 Unknown † Evaluating for Contact Allergies in Patients With Chronic Urticaria
Conditions: Urticaria;   Patch Testing;   Dermatitis;   Allergy;   Contact Sensitization
Intervention: Procedure: Patch Testing
8 Not yet recruiting Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
Condition: Chronic Urticaria
Intervention: Drug: Omalizumab
9 Recruiting Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
Condition: Solar Urticaria
Intervention: Drug: Intravenous immunoglobulins
10 Recruiting Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria
Condition: Chronic Urticaria
Interventions: Biological: Omalizumab;   Biological: Placebo
11 Recruiting Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Both Drugs Alone in High Doses
Condition: Chronic Urticaria
Interventions: Drug: Levocetirizine;   Drug: Hydroxyzine;   Drug: Levocetirizine plus Hydroxyzine
12 Not yet recruiting Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria
Condition: Chronic Urticaria
Interventions: Drug: Chinese Herbal Medicine (CHM);   Drug: Placebo
13 Recruiting Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: IGE025;   Drug: placebo
14 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
15 Recruiting T Cell Function in Chronic Idiopathic Urticaria
Condition: Chronic Urticaria
Intervention:
16 Unknown † The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema
Conditions: Urticaria;   Angioedema
Intervention: Behavioral: Dietary Therapy
17 Recruiting Efficacy Study of Canakinumab to Treat Urticaria
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Canakinumab;   Drug: Placebo
18 Recruiting Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria
Condition: Cold Contact Urticaria
Intervention: Drug: Rupatadine
19 Recruiting Cold Urticaria Treatment With Xolair
Condition: Cold Contact Urticaria
Interventions: Drug: Omalizumab;   Drug: Placebo
20 Recruiting Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy
Conditions: Diagnosis of Chronic Spontaneous Urticaria (CSU) Refractory to H1-antihistamine Treatment;   Presence of Itch an Hives for More Than 6 Weeks;   UAS7 Score of More Than 14 (Range 0-42);   Patient Has History of Insufficient Response to 4x of the Approved Dose of H1-antihistamines;   CSU Diagnosis for More Than 6 Months;   Angioedema at Least 4x in the Last 6 Months
Interventions: Biological: Omalizumab;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years